ViCentra
Founded Year
2013Stage
Series C | AliveTotal Raised
$85.33MLast Raised
$74M | 1 yr agoMissing: ViCentra's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ViCentra's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing ViCentra
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned ViCentra in 1 CB Insights research brief, most recently on Oct 28, 2022.
Expert Collections containing ViCentra
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ViCentra is included in 5 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,623 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Diabetes
2,119 items
Digital Health
10,347 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Health IT
7,901 items
ViCentra Patents
ViCentra has filed 17 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/12/2016 | 3/15/2022 | Sensors, Pumps, User interfaces, Graphical user interfaces, Fluid dynamics | Grant |
Application Date | 12/12/2016 |
|---|---|
Grant Date | 3/15/2022 |
Title | |
Related Topics | Sensors, Pumps, User interfaces, Graphical user interfaces, Fluid dynamics |
Status | Grant |
Latest ViCentra News
Apr 12, 2023
If you are interested in arranging a one-on-one meeting request, please contact your conference representative or Leo Toole at ViCentra. About ViCentra B.V. ViCentra, the company behind Kaleido is based in the Netherlands. Our philosophy is to make innovative products that put people first. With our focus on diabetes, we develop our products not for patients, but for people. We believe that when products are simple, are designed beautifully, and deliver outstanding results. They provide more user enjoyment and help people live better on their own terms. It was with this philosophy in mind that Kaleido was born. Kaleido is a pioneering insulin delivery system for people with type 1 diabetes. Through its unique pulse technology, it provides extremely precise and reliable delivery of insulin, giving its user the peace of mind and freedom that’s often missing for those with a long term health condition. To learn more about ViCentra, visit the Company’s website at https://hellokaleido.com/ . Company Contacts:
ViCentra Frequently Asked Questions (FAQ)
When was ViCentra founded?
ViCentra was founded in 2013.
Where is ViCentra's headquarters?
ViCentra's headquarters is located at Kanaalweg 17, Utrecht.
What is ViCentra's latest funding round?
ViCentra's latest funding round is Series C.
How much did ViCentra raise?
ViCentra raised a total of $85.33M.
Who are the investors of ViCentra?
Investors of ViCentra include INKEF Capital, EQT Life Sciences, Health Innovations, Partners in Equity, Health Innovation Fund and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.